New data show that use of CAPHOSOL an advanced oral electrolyte solution, resulted in both favorable impact on rates and severity of oral mucositis (OM) in cancer patients undergoing chemotherapy and radiation therapy.

New data show that CAPHOSOL, an advanced electrolyte solution, relieves painful oral mucositis (OM) and improves quality of life for cancer patients undergoing chemotherapy and radiation therapy. These data will be reported in two separate presentations, one today in an oral podium presentation and one tomorrow as a poster session, at the 33rd Annual Congress of the Oncology Nursing Society (ONS).